Ionpath + press release
WebIonpath, Inc., is a pioneer in high-definition spatial proteomics, revolutionizing tissue imaging and analysis to accelerate medical discovery and improve human health. … Web11 feb. 2024 · MENLO PARK, California, Feb. 11, 2024 /PRNewswire/ — IONpath, Inc., today announces the launch of a dedicated service business providing access to their proprietary MIBIscope™ multiplexed imaging platform and its team of experts to support pharmaceutical and biotechnology companies working in immuno-oncology. IONpath …
Ionpath + press release
Did you know?
Web5 nov. 2024 · MIBIscope allows researchers to visualize over 40 biomarkers simultaneously with high resolution, sensitivity, and throughput, and is compatible with standard tissue processing techniques Menlo Park, Calif. – IONpath, Inc., a company revolutionizing multiplexed tissue imaging, launched the MIBIscope™ System, the first commercially … WebMultiplexed Ion Beam Imaging (MIBI™) technology from Ionpath enables high-definition spatial proteomics that uniquely provides actionable analysis of the tissue microenvironment—delivering novel insights into disease …
Web8 nov. 2024 · Several studies highlight utility of Ionpath’s multiplexed ion beam imaging (MIBI) technology in spatial proteomics applications. MENLO PARK, Calif.--(BUSINESS WIRE)--Ionpath, a pioneer in high-definition spatial proteomics, today announced that the results of several studies enabled by multiplexed ion beam imaging (MIBI™) technology … WebIonpath is a developer of an ion beam imaging technology used to provide analysis of tissue biopsies. Its imaging technology surpasses light microscopy to analyze whether the …
Web11 mei 2024 · MENLO PARK, Calif.-- (BUSINESS WIRE)-- #oncology --Ionpath, Inc., a leader in high-definition spatial proteomics, today announced that Thermo Fisher Scientific, the world leader in serving science, has made a strategic investment in the company. Details of the investment are not being disclosed. WebGenerating Revenue. 1. Early Stage VC (Series A1) $2.6M. $2.6M. 00.00. Completed. Startup. To view Ionpath’s complete valuation and funding history, request access ».
Web24 sep. 2024 · MENLO PARK, Calif., Sept. 24, 2024 /PRNewswire/ -- IONpath, Inc., the leader in high-definition spatial proteomics, today announced the close of a $18 million Series B financing led by Samsara...
Web1 nov. 2024 · Accomplished scientist and business executive brings nearly two decades of experience working on commercial strategies and operations in life sciences MENLO PARK, Calif. — Ionpath, a pioneer in high-definition spatial proteomics, announced today that Goran Pljevaljcic has joined the company as its Chief Commercial Officer. In this … ezebra na allegroWeb24 sep. 2024 · MENLO PARK, Calif., Sept. 24, 2024 /PRNewswire/ -- IONpath, Inc., the leader in high-definition spatial proteomics, today announced the close of a $18 million … hgriaWebIONpath is a California-based biotechnology company that manufactures and supplies spatial proteomics and tissue imaging systems for the healthcare industry. IONpath’s … ezebreak llcWebMIBI™ technology (Multiplexed Ion Beam Imaging) uses Secondary-Ion Mass Spectrometry (SIMS), a type of mass spectrometry traditionally used in the semiconductor industry, to image antibodies tagged with monoisotopic metal reporters. This unique technology enables: Visualization of 40+ markers simultaneously. Imaging at the sub … hgr industrial surplus birmingham alabamaWeb10 mei 2024 · IonPath, Inc. announced that it will issue 70,531,242 voting series C preferred shares at a price of $1.0455 per share for the gross proceeds of … ezebra uaWeb24 sep. 2024 · Proceeds will be used for the further development and deployment of IONpath’s revolutionary MIBI technology, affirming its leadership in high-definition spatial proteomics MENLO PARK, Calif. — IONpath, Inc., the leader in high-definition spatial proteomics, today announced the close of a $18 million Series B financing led by … hgr guadalajaraWebThe MIBIscope enables over 40 markers to be visualized simultaneously with single step staining and single step imaging. MIBIscope images from a 3mm x 3mm scan of a granulomatous lung section from a Mycoplasm tuberculosis infected patient. The image to the left shows immune infiltrate in the infected tissue (CD45, yellow; CD31, red; SMA, … ezebra seriös